This company is no longer active

The company may no longer be operating, as it may be out of business. Find out why through their latest events.

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Chr. Hansen Holding Beheer

Beheer criteriumcontroles 4/4

We currently do not have sufficient information about the CEO.

Belangrijke informatie

Mauricio Graber

Algemeen directeur

€3.2m

Totale compensatie

Percentage CEO-salaris	31.3%
Dienstverband CEO	5yrs
Eigendom CEO	0.02%
Management gemiddelde ambtstermijn	5.7yrs
Gemiddelde ambtstermijn bestuur	4.1yrs

Recente managementupdates

Recent updates

Analyse CEO-vergoeding

Hoe is Mauricio Graber's beloning veranderd ten opzichte van Chr. Hansen Holding's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Feb 28 2023	n/a	n/a	€229m
Nov 30 2022	n/a	n/a	€228m
Aug 31 2022	€3m	€1m	€225m
May 31 2022	n/a	n/a	€230m
Feb 28 2022	n/a	n/a	€221m
Nov 30 2021	n/a	n/a	€209m
Aug 31 2021	€3m	€986k	€199m
May 31 2021	n/a	n/a	€199m
Feb 28 2021	n/a	n/a	€213m
Nov 30 2020	n/a	n/a	€222m
Aug 31 2020	€3m	€969k	€232m
May 31 2020	n/a	n/a	€218m
Feb 29 2020	n/a	n/a	€221m
Nov 30 2019	n/a	n/a	€224m
Aug 31 2019	€3m	€953k	€229m
May 31 2019	n/a	n/a	€246m
Feb 28 2019	n/a	n/a	€240m
Nov 30 2018	n/a	n/a	€233m
Aug 31 2018	€2m	€238k	€228m

Compensatie versus markt: Mauricio's total compensation ($USD3.45M) is about average for companies of similar size in the MX market ($USD2.75M).

Compensatie versus inkomsten: Mauricio's compensation has been consistent with company performance over the past year.

CEO

Mauricio Graber (60 yo)

5yrs

Tenure

€3,209,000

Compensatie

Mr. Mauricio Graber has been Chief Executive Officer, President and Member of Executive Board of Chr. Hansen Holding A/S since joining it on June 1, 2018. Mr. Graber serves as Director of Jungbunzlauer Sui...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Mauricio Graber	CEO, President & Member of Executive Board	5yrs	€3.21m	0.024% MX$ 39.0m
Lise Mortensen	Executive VP	2.7yrs	€1.32m	0.0021% MX$ 3.5m
Thomas Schafer	Chief Science Advisor	1.3yrs	€1.58m	geen gegevens
Torsten Steenholt	Executive Vice President of Global Operations	6.4yrs	geen gegevens	geen gegevens
Henrik Nielsen	Executive VP & Chief Scientific Officer	1.2yrs	geen gegevens	geen gegevens
Anders Christensen	Vice President Group Strategy & Investor Relations	no data	geen gegevens	geen gegevens
Winnie Bugel	Executive Vice President of Compliance & Corporate Affairs	7yrs	geen gegevens	geen gegevens
Sanne Seyer-Hansen	Head of Media Relations	no data	geen gegevens	geen gegevens
Alice Larsen	Executive Vice President of Human Resources	6.9yrs	geen gegevens	geen gegevens
Laurent Hubert	VP & Head of Food	no data	geen gegevens	geen gegevens
Jacob Paulsen	Executive Vice President of Food Cultures & Enzymes	6.8yrs	geen gegevens	geen gegevens
Christian Barker	Executive Vice President of Health & Nutrition	no data	geen gegevens	geen gegevens

5.7yrs

Gemiddelde duur

55yo

Gemiddelde leeftijd

Ervaren management: CHR N's management team is seasoned and experienced (5.7 years average tenure).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Jesper Brandgaard	Independent Vice Chairman	5.6yrs	€154.00k	0.0035% MX$ 5.8m
Dominique J. Reiniche	Independent Chairman of the Board	9.6yrs	€266.00k	0.0019% MX$ 3.1m
Luis Rocamora	Independent Director	6.6yrs	€116.00k	0.0017% MX$ 2.8m
Kasim Kutay	Representative Non Independent Director	less than a year	geen gegevens	geen gegevens
Heidi Kleinbach-Sauter	Independent Director	5.6yrs	€107.00k	0.00065% MX$ 1.1m
Heine Dalsgaard	Representative Non Independent Director	less than a year	geen gegevens	geen gegevens
Charlotte Hemmingsen	Employee Representative Director	5.6yrs	€59.00k	0.00086% MX$ 1.4m
Kim Soerensen	Employee Representative Director	5.6yrs	€59.00k	0.000080% MX$ 132.5k
Kevin Lane	Independent Director	2.6yrs	€109.00k	0.00076% MX$ 1.3m
Lise Kaae	Independent Director	2.6yrs	€105.00k	0.0010% MX$ 1.7m
Casper Giedo	Employee Representative Director	1.6yrs	€45.00k	0.000020% MX$ 33.1k
Karen Lauesen	Employee Representative Director	1.6yrs	€45.00k	0.000040% MX$ 66.2k

4.1yrs

Gemiddelde duur

58.5yo

Gemiddelde leeftijd

Ervaren bestuur: CHR N's board of directors are considered experienced (4.1 years average tenure).

This company is no longer active

Chr. Hansen Holding Beheer

Beheer criteriumcontroles 4/4

Belangrijke informatie

Recente managementupdates

Novozymes A/S and Chr. Hansen Announce Executive Leadership Team and Organizational Structure

Executive VP recently bought Mex$1.5m worth of stock

Key Executive recently bought Mex$135k worth of stock

High number of new directors

High number of new directors

High number of new directors

Recent updates

Chr. Hansen Holding A/S(CPSE:CHR) dropped from FTSE All-World Index (USD)

Chr. Hansen Holding A/S(CPSE:CHR) dropped from OMX Copenhagen 20 Index

Novozymes A/S (CPSE:NZYM B) completed the acquisition of Chr. Hansen Holding A/S (CPSE:CHR).

Novozymes A/S (CPSE:NZYM B) completed the acquisition of Chr. Hansen Holding A/S (CPSE:CHR).

Chr. Hansen Holding A/S to Report Fiscal Year 2024 Results on Feb 06, 2025

Chr. Hansen Holding A/S Revises Revenue Guidance for January 1, 2023 – December 31, 2023

Novozymes A/S and Chr. Hansen Announce Executive Leadership Team and Organizational Structure

Chr. Hansen Holding A/S Provides Earnings Guidance for the Period September 1, 2022 – August 31, 2023

Executive VP recently bought Mex$1.5m worth of stock

First quarter 2023 earnings released: EPS: €0.38 (vs €0.35 in 1Q 2022)

Chr. Hansen Holding A/S Provides Revenue Guidance for 2022/23

Novozymes A/S (CPSE:NZYM B) agreed to acquire Chr. Hansen Holding A/S (CPSE:CHR).

Novozymes A/S (CPSE:NZYM B) agreed to acquire Chr. Hansen Holding A/S (CPSE:CHR).

Key Executive recently bought Mex$135k worth of stock

Chr. Hansen Holding A/S Approves Ordinary Dividend

Upcoming dividend of kr.7.04 per share

High number of new directors

Chr. Hansen Holding A/S to Report Q1, 2023 Results on Dec 12, 2022

Full year 2022 earnings released: EPS: €1.71 (vs €1.51 in FY 2021)

Chr. Hansen Holding A/S Proposes Ordinary Dividend for 2021/22

High number of new directors

Chr. Hansen Holding A/S to Report Q2, 2023 Results on Apr 13, 2023

Third quarter 2022 earnings released: EPS: €0.45 (vs €0.38 in 3Q 2021)

Chr. Hansen Holding A/S Provides Earnings Guidance for the Full Year of Fiscal 2022

High number of new directors

Analyse CEO-vergoeding

CEO

Tenure

Compensatie

Leiderschapsteam

Gemiddelde duur

Gemiddelde leeftijd

Bestuursleden

Gemiddelde duur

Gemiddelde leeftijd